Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Our competion?

lia,

great article! i was looking it up last night and didn't come across anything near this comprehensive. then i also saw where GBNT is like .08$/share and doesn't look like it's going anywhere soon. you are right this is loooong way away. i wish it was closer to being a finished product because like afrezza, it would be a game changer and good for diabetics. and if it had good science and prospects i'm sure we'd look to invest in it as well. maybe in 4-5 years it will be more on the radar.

chad

Share
New Message
Please login to post a reply